Menopause International > Volume 14, Number 1 > Pp. 33-37

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Lane, G. Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Review

Obesity and gynaecological cancer

Geoffrey Lane

St James's Hospital, Leeds, UK

Correspondence: Geoffrey Lane, Gynaecological Oncologist, St James's Hospital, Beckett Street, Leeds LS9 7TF, UK. Email: geoffrey.lane{at}leedsth.nhs.uk
Obesity is now considered to be a global epidemic. The problem of obesity has significant implications for the diagnosis and treatment of gynaecological cancer. The cancer most frequently associated with obesity is that of the endometrium. The risk of endometrial cancer is 2–3 times higher in overweight and obese women. Obesity also adversely affects survival in most studies. With regard to ovarian cancer the evidence is inconsistent. Obesity in young adulthood may be more important than that in later life. With regard to survival obesity has an adverse effect but not in early stage disease. Few data are available regarding cervical cancer and obesity. There is evidence that obesity is associated with adenocarcinoma rather than squamous carcinoma. Data on vulval cancer and obesity are scant.

Key Words: Endometrial cancer • gynaecological cancer • obesity • ovarian cancer • overweight

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?